﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Hamadan University of Medical Sciences</PublisherName>
      <JournalTitle>Avicenna Journal of Medical Biochemistry</JournalTitle>
      <Issn>2345-4113</Issn>
      <Volume>9</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2021</Year>
        <Month>12</Month>
        <DAY>29</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Anti-inflammatory and Antioxidant Properties of PLGA Nanoparticles Produced From Kombucha Extract on A2780 Human Ovarian Cancer Cell Line</ArticleTitle>
    <FirstPage>65</FirstPage>
    <LastPage>71</LastPage>
    <ELocationID EIdType="doi">10.34172/ajmb.2021.12</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Sara</FirstName>
        <LastName>Ghandehari</LastName>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Homayouni Tabrizi</LastName>
      </Author>
      <Author>
        <FirstName>Jafar</FirstName>
        <LastName>Izadi Nia</LastName>
      </Author>
      <Author>
        <FirstName>Mohammad Taghi</FirstName>
        <LastName>Goodarzi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-5546-5812</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/ajmb.2021.12</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2021</Year>
        <Month>11</Month>
        <Day>29</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2021</Year>
        <Month>12</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <Abstract>Background: Anti-cancer agents encapsulated in nanoparticles (NPs) can result in higher efficiency. Kombucha is a fermented tea beverage, and previous reports support its anti-cancer properties. Objectives: The present study aimed to evaluate the anti-cancer and anti-inflammatory properties of poly (lactic-co-glycolic acid) loaded Kombucha NPs (PLGA-K-NPs) against the A2780 human ovarian cancer cell line. Methods: The antioxidant activity was analyzed using ferric reducing ability of plasma and 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) assays, along with the measurement of catalase (CAT) gene expression. The gene expression of three interleukins (IL-1β, IL-6, and IL-10) was also determined to demonstrate the anti-inflammatory properties of NPs. Results: The results revealed the antioxidant effects of PLGA-K-NPs on the studied cell lines by increasing Fe3+ reduction, inhibiting the free radical formation (P&lt;0.001), and increasing the expression of the CAT gene (P&lt;0.001). In addition, NPs could significantly elevate the gene expression of IL-10 (P&lt;0.01) as an anti-inflammatory cytokine at a 40 µg/mL concentration, while reducing the expression of IL-1β and IL-6, and inflammatory cytokines at all tested concentrations (P&lt;0.01). Conclusion: According to the obtained results, PLGA-K-NPs have anti-inflammatory and anti-oxidant properties, therefore, they can be considered as a compound in the treatment of ovarian cancer. However, it needs to be further investigated in animal studies to clarify more details. </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Antioxidant effects</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Inflammation</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Kombucha extract</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Ovarian cancer</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Poly (Lactic-co-glycolic Acid) nanoparticles.</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>